Biologics

Mar 31, 2015
By Pharmaceutical Technology Editors
Merck Serono announces that it will work with Intrexon to develop a cancer therapy using chimeric antigen receptor T-cells.
PTSM: Pharmaceutical Technology Sourcing and Management: Mar 30, 2015
By Pharmaceutical Technology Editors
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
Mar 24, 2015
Clinical trial results suggest that monoclonal antibodies targeting the function of proinflammatory cytokine IL-17A in psoriasis may be significantly superior to other treatments.
Pharmaceutical Technology: Mar 23, 2015
By Pharmaceutical Technology Editors
Guidance provides labeling standards and an implementation guide for electronic submission of lot distribution reports.
Mar 18, 2015
By Pharmaceutical Technology Editors
WuXi's new facility in Philadelphia will manufacture CAR T-cell therapies and other cancer immunotherapies.
Pharmaceutical Technology: Mar 13, 2015
BIO and the Colorado BioScience Association urge Colorado Governor Hickenlooper to sign a bill that will help patients gain access to interchangeable biologic products following FDA approvals.
Mar 06, 2015
In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Mar 06, 2015
By Pharmaceutical Technology Editors
Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.
Mar 05, 2015
By Pharmaceutical Technology Editors
Baxter has bought SuppreMol, a German biopharmaceutical company that focuses on autoimmune treatments, for €200 million ($225 million USD).